CASTLE CARBIDE LIMITED
Company number 02511524 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
1. Financial Health Score: B-
Explanation: Castle Carbide Limited exhibits the vital signs of a stable but sluggish patient. The company has excellent liquidity (a strong "heartbeat" of cash) and has successfully reduced its short-term debts, indicating good short-term survival prospects. However, it is suffering from severe profitability "anemia"—generating a negligible profit relative to its asset base. The business is surviving, but not thriving or building financial muscle.
2. Key Vital Signs
- Pulse (Cash Position): Strong. Cash at bank increased slightly from £614,482 to £632,240. The company is well-hydrated and does not face an immediate cash crisis.
- Blood Pressure (Liquidity Ratio): Healthy. Current assets (£1.55M) comfortably exceed current liabilities (£1.11M), giving a current ratio of approximately 1.4:1. The company can easily cover its immediate obligations.
- Cholesterol (Debt Levels): Elevated but Improving. Total liabilities decreased from £1.29M to £1.11M. The patient is reducing its "bad cholesterol" (short-term creditors), which is a positive trend for cardiovascular health.
- Metabolism (Profitability): Dangerously Low. The Profit and Loss reserve grew by only £850 (from £572,764 to £573,614). For a business with £1.5M in assets, this represents a flatlining metabolism—barely enough to keep the organs functioning.
- Muscle Mass (Fixed Assets): Mildly Atrophied. Tangible assets decreased from £220,624 to £200,289. The business is consuming its existing fixed assets (depreciation) faster than it is investing in new ones (capital expenditure), suggesting a lack of reinvestment in future capacity.
3. Diagnosis
Assessment: Stable Condition, but suffering from Strategic Stagnation
The financial data reveals a business that is financially solvent but operationally lethargic.
Symptoms of Distress: The most alarming symptom is the near-zero profitability. A profit of £850 on a balance sheet of this size suggests that the core business model is either under severe margin pressure or that profits are being extracted in a manner that leaves the P&L reserve bare (though no dividend movement is explicitly visible in the equity).
Working Capital Dynamics: The balance sheet shows a simultaneous contraction in both debtors (down from £1.08M to £914k) and creditors (down from £1.29M to £1.11M). This is a classic symptom of a business "slimming down"—either due to a reduction in sales volume or a deliberate strategy to tighten working capital cycles. While paying down creditors is healthy, the drop in debtors suggests the business pipeline may be shrinking.
The Inventory Anomaly: Stocks remain incredibly low at just £550. For a company classified under "Manufacture of tools" (SIC 25730), this is highly unusual. It suggests the company operates primarily as an importer/distributor with a just-in-time model, or perhaps acts as a holding entity/agent for the parent company (Dudley Shaw Holdings Limited). It does not carry the physical inventory typical of a traditional manufacturer.
Hidden Conditions: The company is owned by a corporate PSC (Dudley Shaw Holdings Limited). This structural symptom suggests that Castle Carbide may be part of a larger group anatomy. The low profitability might be the result of transfer pricing or group management charges shifting profits to the parent entity, meaning the "anemia" might be a deliberate group strategy rather than a market failure.
4. Recommendations
To improve financial wellness and move from surviving to thriving, the following treatments are prescribed:
- Vitamin P (Profitability) Injection: Conduct an immediate review of pricing strategies and cost of sales. A return on assets of 0.05% is unsustainable in the long term; the business needs to ensure each sale contributes adequately to the bottom line.
- Cardiovascular Exercise (Cash Circulation): While cash levels are healthy, holding £632k in the bank without reinvestment is like stagnant water. Evaluate whether this cash can be deployed into higher-yield investments, R&D, or marketing to stimulate revenue growth.
- Muscle Building (Capital Expenditure): The reduction in tangible assets suggests the equipment is aging. Ensure that the business is not deferring necessary capital expenditure to maintain operational efficiency and competitive edge.
- Group Health Check: Given the PSC ownership, review inter-company balances and group strategies. Ensure that Castle Carbide is not unduly bearing costs while profits are recognized elsewhere in the group structure.